As per Future Market Insights' latest industry analysis, the Immunohistochemistry Market Size is expected to be worth US$ 2.05 billion in 2022 and US$ 4.59 billion by 2032, with a quick CAGR of 8.4% between 2022 and 2032.
The rise in healthcare spending and the surge in interest in living a better life are expected to drive up adoption of immunohistochemistry.
The immunohistochemistry market is expected to grow due to an increase in chronic diseases. As value-based healthcare solutions become more popular, it is expected that demand for immunohistochemistry will skyrocket.
The immunohistochemistry market share is expected to grow as the number of patients with cancer, infectious diseases, and cardiovascular disorders increases, all of which use immunohistochemistry for diagnosis.
The rapid spread of infectious diseases presents a challenge for medical professionals in developing drugs for such unidentified diseases. Immunohistochemistry demand for such diseases is expected to drive immunohistochemistry market growth.
According to the International Diabetes Federation, 463 million people aged 20 to 79 have diabetes worldwide in 2019, with that figure expected to rise to nearly 700 million by 2045.
Immunohistochemistry market growth is expected to be driven by increased R&D in immunohistochemistry-based techniques in the coming years.
Furthermore, the use of immunohistochemistry is expected to increase over the projected period due to an increase in the incidence and prevalence of chronic diseases such as cancer, in which proteins are expected to play a significant role. The immunohistochemistry industry's short-term growth is expected to be hampered by unfavourable reimbursement regulations.
Key Takeaways from Market Study
- Because antibodies are so important in disease diagnosis and medication testing, the antibodies segment is expected to dominate the immunochemistry market in 2021, accounting for more than 41% of global revenue.
- In 2021, hospitals and diagnostic laboratories generated more than 71% of total revenue, dominating the immunochemistry market.
- North America is expected to command more than 39% of global immunochemistry sales in 2021.
- Asia Pacific is expected to have the fastest CAGR during the forecast period. This is largely due to global players increased geographic presence in Asian markets.
"Increased automation and machine learning deployment in immunohistochemistry (IHC), as well as the release of technologically enhanced IHC solutions, are expected to drive immunohistochemistry market share significantly during the forecast period. The use of immunohistochemistry in disease diagnosis has grown significantly as IHC methods have advanced." Analyst, Future Market Insights
Competitive Landscape
Key immunohistochemistry market players are developing cutting-edge products that will drive immunohistochemistry market growth.
The introduction of these clinical diagnostic markers could aid in the advancement of early cancer medication development in the immuno-oncology field. Due to R&D advancements, the immunohistochemistry market is expected to expand at a faster rate during the forecast period.
The following companies are among the major players in the global immunohistochemistry market: Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Merck KGaA; Danaher Corporation; PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB; Abcam plc., Agilent Technologies, Inc.
Key Segments
By Product:
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Equipment
- Slide Staining System
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Others
- Reagents
- Histological stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Kits
By Application:
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Drug Testing
By End-use:
- Hospitals & Diagnostic Laboratories
- Research Institutes
- Others
Click to get detail Research Report@ https://www.futuremarketinsights.com/reports/immunohistochemistry-market
The global immunohistochemistry market size is expected to reach a value of USD 3.2 billion by 2027, expanding at a CAGR of 7.8%, according to a new report by Radiant Insights, Inc.
IHC has become a crucial technique and is widely applied in the diagnosis of several chronic diseases such as cancer, infectious diseases, and cardiovascular diseases (CVDs).
Thus, a rise in the incidence of these chronic diseases has led to an increase in the demand for IHC techniques.
According to 2018 data published by WHO, globally, cancer was one of the leading causes of mortality, and in 2018 around 9.6 million deaths were registered due to cancer.
Additionally, in June 2019, the U.S. FDA approved the expanded use of Agilent Technologies’ PD-L1 IHC 22C3 pharmDx assay for the detection of head and neck squamous cell carcinoma (HNSCC).
This product is used in patients receiving treatment with Merck and Co., Inc.’s Keytruda (Pembrolizumab).
According to the new market research report “Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User – Global Forecast to 2021″, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).Don’t miss out on business opportunities in Immunohistochemistry Market.Speak to our analyst and gain crucial industry insights that will help your business grow:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121632939The immunohistochemistry market is projected to reach USD 2.12 Billion by 2021, at a CAGR of 7.3% during the forecast period.
Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years.
However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the market.Immunohistochemistry (IHC) is a laboratory test that uses antibodies to test certain antigens in a tissue combining immunological, anatomical, and biochemical techniques.
There are multiple approaches and permutation in immunohistochemistry applicable in drug testing and diagnosis of chronic diseases like cancer, infectious diseases, cardiovascular diseases, diabetes, and autoimmune diseases.
The market covers the market size from 2014 to 2021.Browse and in-depth TOC on ” Immunohistochemistry Market”181 – Tables44 – Figures225 – PagesRequest for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=121632939Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years.
However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine are expected to offer significant growth opportunities for players in the market.
Global Immunohistochemistry Market OverviewThe Global Immunohistochemistry Market report draws accurate insights by examining the latest and prospective industry trends, helping the readers recognize the products and services that are boosting revenue growth and profitability.
The study performs a detailed analysis of all the significant factors impacting the market on a global and regional scale, including drivers, constraints, threats, challenges, prospects, and industry-specific trends.
This study assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.Check out the Sample Report here: https://www.reportsanddata.com/sample-enquiry-form/2198The Immunohistochemistry market analysis is intended to provide all participants and vendors with pertinent specifics about growth aspects, roadblocks, threats, and lucrative business opportunities that the market is anticipated to reveal in the coming years.
This intelligence study also encompasses the revenue share, market size, production capacity, and rate of consumption to draw insights pertaining to the rivalry to gain control of a large portion of the market share.Leading Players in the Immunohistochemistry Market:Abcam plc; Bio SB; Bio-Rad Laboratories Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; F. Hoffmann-La Roche AG; Merck KGaA;, Inc.; Thermo Fisher Scientific, Inc., PerkinElmer, Agilent TechnologiesCompetitive landscapeThe Immunohistochemistry Industry is extremely competitive and consolidated because of the existence of several established companies that are adopting different marketing strategies in order to increase their market share.
The vendors are gradually expanding their focus on product personalization by way of customer interaction.
Immunohistochemistry Market segment by : Type (Revenue, USD Million; 2016–2026)AntibodiesEquipmentReagentsKitsApplication (Revenue, USD Million; 2016–2026)DiagnosticsCancerInfectious DiseasesCardiovascular DiseasesAutoimmune DiseasesDiabetes MellitusNephrological DiseasesDrug TestingEnd Use (Revenue, USD Million; 2016–2026)Hospitals and Diagnostic LaboratoriesClinicsResearch InstitutesOthers Regional Immunohistochemistry Market (Regional Output, Demand & Forecast by Countries):- North America (United States, Canada, Mexico)South America (Brazil, Argentina, Ecuador, Chile)Asia Pacific (China, Japan, India, Korea)Europe (Germany, UK, France, Italy)Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) and More.Connect with an expert for customization of Report : @ https://www.reportsanddata.com/request-customization-form/2198Points Covered in The Report:A.
